To determine whether this effect was related to DpA modulation, a tyrosine hydroxylase expression-based assay was carried out, showing that 160 could act in restoring DpA in the SN and striatum, highlighting its therapeutic potential against PD as a multi-functional ligand [47]. The gene discussed is TH; the disease is Parkinson disease.